Literature DB >> 8897451

Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.

L Moreno1, M A Martínez-Cuesta, J M Piqué, J Bosch, J V Esplugues.   

Abstract

The present study evaluates the effects of pre-hepatic portal hypertension, induced in rats by partial portal vein ligation, on the responsiveness of rostral (proximal) and caudal (distal) rings from the mesenteric vein. The anatomical origin of the sample influenced the response to vasoconstrictors in sham-operated animals, and this pattern of reactivity was specifically modified in portal-ligated rats. In veins from sham-operated rats, contraction induced by a submaximal concentration of KCl (60 mM) was greater in proximal than in distal rings. Vasopressin and 5-hydroxytryptamine contracted mainly distal rings, methoxamine showed a greater effect on proximal rings, and endothelin-1 and angiotensin-II contracted vein rings independently of their anatomical origin. In veins from portal hypertensive rats, response to KCl (60 mM) were increased in distal rings, and all rings exhibited enhanced reactivity to vasopressin and 5-hydroxyptyptamine as well as attenuation of the response to methoxamine. Responses to endothelin-1 were decreased in proximal vein rings from portal hypertensive rats whereas responses to angiotensin-II were not influenced by the anatomical origin. Incubation with atropine, propranolol or indomethacin, did not modify the responses to vasopressin and 5-hydroxytryptamine in tissues from either sham-operated or portal hypertensive animals. Likewise, the hyporeactivity to methoxamine and endothelin-1 in rings from portal hypertensive rats persisted in the presence of the nitric oxide inhibitor NG-nitro-L-arginine methyl ester. These results suggest the physiological existence of anatomical differences in the responsiveness to vasoconstrictors throughout the mesenteric vein and that changes in the responsiveness of the mesenteric vein induced by portal hypertension are specific for each agonist and possibly result from individual variations at a receptor or post-receptor level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897451     DOI: 10.1007/bf00168439

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

Review 1.  Pathophysiology of portal hypertension.

Authors:  J Bosch; P Pizcueta; F Feu; M Fernández; J C García-Pagán
Journal:  Gastroenterol Clin North Am       Date:  1992-03       Impact factor: 3.806

2.  The treatment of portal hypertension: a meta-analytic review.

Authors:  G D'Amico; L Pagliaro; J Bosch
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

3.  Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.

Authors:  J V Sitzmann; S S Li; P W Lin
Journal:  J Surg Res       Date:  1989-09       Impact factor: 2.192

4.  Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

Authors:  J W Kiel; V Pitts; J N Benoit; D N Granger; A P Shepherd
Journal:  Am J Physiol       Date:  1985-02

5.  Endogenous vasoconstrictor tone in intestine of normal and portal hypertensive rats.

Authors:  T Joh; D N Granger; J N Benoit
Journal:  Am J Physiol       Date:  1993-01

6.  Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats.

Authors:  S A Cummings; R J Groszmann; A J Kaumann
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

Review 7.  Treatment of acute variceal bleeding.

Authors:  D S Matloff
Journal:  Gastroenterol Clin North Am       Date:  1992-03       Impact factor: 3.806

8.  Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats.

Authors:  J F Liao; P C Yu; H C Lin; F Y Lee; J S Kuo; M C Yang
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

9.  Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

Authors:  M Chojkier; R J Groszmann
Journal:  Am J Physiol       Date:  1981-05

10.  Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats.

Authors:  S Karatapanis; P A McCormick; S Kakad; J K Chin; M Islam; J Jeremy; D Harry; N McIntyre; A K Burroughs; M Jacobs
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  3 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Gastric mucosal resistance to acute injury in experimental portal hypertension.

Authors:  S Calatayud; M C Ramírez; M J Sanz; L Moreno; C Hernández; J Bosch; J M Piqué; J V Esplugues
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 3.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.